These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32298597)

  • 21. Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes.
    Tavira B; Coto E; Díaz-Corte C; Ortega F; Arias M; Torres A; Díaz JM; Selgas R; López-Larrea C; Campistol JM; Alvarez V;
    Clin Chem Lab Med; 2011 May; 49(5):825-33. PubMed ID: 21480817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of genetic polymorphisms of CYP3A5 and ABCB1 on sirolimus pharmacokinetics, patient and graft survival and other clinical outcomes in renal transplant.
    Rodríguez-Jiménez C; García-Saiz M; Pérez-Tamajón L; Salido E; Torres A
    Drug Metab Pers Ther; 2017 Mar; 32(1):49-58. PubMed ID: 28245187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome.
    Laika B; Leucht S; Heres S; Schneider H; Steimer W
    Pharmacogenomics J; 2010 Feb; 10(1):20-9. PubMed ID: 19636338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
    Tantawy AA; El-Bostany EA; Adly AA; Abou El Asrar M; El-Ghouroury EA; Abdulghaffar EE
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single nucleotide polymorphisms in the NER pathway and clinical outcome of patients with bone malignant tumors.
    Sun XH; Hou WG; Zhao HX; Zhao YL; Ma C; Liu Y
    Asian Pac J Cancer Prev; 2013; 14(3):2049-52. PubMed ID: 23679317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic polymorphisms of the CYP3A4, CYP3A5, CYP3A7 and CYP1A2 among the Jordanian population.
    Salameh G; Al Hadidi K; El Khateeb M
    Environ Toxicol Pharmacol; 2012 Jul; 34(1):23-33. PubMed ID: 22426036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CYP1A2-163C/A (rs762551) polymorphism and bladder cancer risk: a case-control study.
    Song YL; Wang L; Ren JC; Xu ZH
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study.
    Windsor RE; Strauss SJ; Kallis C; Wood NE; Whelan JS
    Cancer; 2012 Apr; 118(7):1856-67. PubMed ID: 21887680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.
    Carlquist JF; Horne BD; Muhlestein JB; Lappé DL; Whiting BM; Kolek MJ; Clarke JL; James BC; Anderson JL
    J Thromb Thrombolysis; 2006 Dec; 22(3):191-7. PubMed ID: 17111199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.
    Chen X; Wang L; Zhi L; Zhou G; Wang H; Zhang X; Hao B; Zhu Y; Cheng Z; He F
    Clin Pharmacol Ther; 2005 Sep; 78(3):249-59. PubMed ID: 16153396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive impact of common variations in DNA repair genes on clinical outcome of osteosarcoma.
    Bai SB; Chen HX; Bao YX; Luo X; Zhong JJ
    Asian Pac J Cancer Prev; 2013; 14(6):3677-80. PubMed ID: 23886164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population.
    Hilli J; Rane A; Lundgren S; Bertilsson L; Laine K
    Fundam Clin Pharmacol; 2007 Aug; 21(4):379-86. PubMed ID: 17635176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver Transplant Patient Carriers of Polymorphism Cyp3a5*1 Donors May Need More Doses of Tacrolimus From the First Month After Transplantation.
    Argudo A; González de Aledo JM; Alía P; Ramírez P; Serrano T; Fabregat J; Castellote J
    Transplant Proc; 2015 Oct; 47(8):2388-92. PubMed ID: 26518936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Association of CYP2C19 and CYP3A5 gene polymorphisms with myocardial infarction].
    Qi L; Liang W; Qiao H; Wang R; Han J; Xing X; Hu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Jan; 38(1):87-91. PubMed ID: 33423267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between hypertension and coffee drinking based on CYP1A2 rs762551 single nucleotide polymorphism in Taiwanese.
    Hou CC; Tantoh DM; Lin CC; Chen PH; Yang HJ; Liaw YP
    Nutr Metab (Lond); 2021 Aug; 18(1):78. PubMed ID: 34391463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of CYP1A2 genotype on the ergogenic properties of caffeine during resistance exercise: a randomized, double-blind, placebo-controlled, crossover study.
    Rahimi R
    Ir J Med Sci; 2019 Feb; 188(1):337-345. PubMed ID: 29532291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between TGF-β1 gene 29 T > C single nucleotide polymorphism and clinicopathological characteristics of osteosarcoma.
    Wu Y; Zhao J; He M
    Tumour Biol; 2015 Jul; 36(7):5149-56. PubMed ID: 25663491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase.
    Aouam K; Kolsi A; Kerkeni E; Ben Fredj N; Chaabane A; Monastiri K; Boughattas N
    Pharmacogenomics; 2015 Dec; 16(18):2045-54. PubMed ID: 26615671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYP1A2--a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients.
    Simonsson M; Veerla S; Markkula A; Rose C; Ingvar C; Jernström H
    BMC Cancer; 2016 Mar; 16():256. PubMed ID: 27029552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.
    Jaquenoud Sirot E; Knezevic B; Morena GP; Harenberg S; Oneda B; Crettol S; Ansermot N; Baumann P; Eap CB
    J Clin Psychopharmacol; 2009 Aug; 29(4):319-26. PubMed ID: 19593168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.